Does Rallies show 13F holders for SRTS?

Yes. Rallies tracks hedge fund and 13F ownership data for SRTS, including fund names, share counts, latest tracked quarter, and position changes when available.

Is SRTS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SRTS. It does not provide personalized investment advice.

SRTS (Sensus Healthcare, Inc) Stock Analysis - Hedge Fund Holdings

Sensus Healthcare, Inc (SRTS) is a publicly traded Healthcare sector company. As of May 21, 2026, SRTS trades at $3.07 with a market cap of $57.12M and a P/E ratio of -6.94. SRTS moved -2.84% today. Year to date, SRTS is -25.39%; over the trailing twelve months it is -30.83%. Its 52-week range spans $2.82 to $9.33. Analyst consensus is strong buy with an average price target of $5.67. Rallies surfaces SRTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns SRTS stock?

Hedge funds tracked by Rallies that own SRTS include Renaissance Technologies, Two Sigma, Citadel Advisors, and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sensus Healthcare, Inc.

SRTS Key Metrics

Key financial metrics for SRTS
Metric	Value
Price	$3.07
Market Cap	$57.12M
P/E Ratio	-6.94
EPS	$-0.47
Dividend Yield	0.00%
52-Week High	$9.33
52-Week Low	$2.82
Volume	128
Avg Volume	0
Revenue (TTM)	$22.53M
Net Income	$-7.77M
Gross Margin	37.74%

Top Hedge Funds Holding SRTS

Renaissance Technologies holds 430.93K shares of SRTS, changed +5.28% as of Dec 31, 2024.
Two Sigma holds 90.52K shares of SRTS, changed -41.24% as of Dec 31, 2024.
Citadel Advisors holds 78.89K shares of SRTS, changed +3.41% as of Dec 31, 2024.
Two Sigma holds 10.80K shares of SRTS, changed -87.38% as of Dec 31, 2024.

Latest SRTS News

Sensus Healthcare director buys 1,500 shares as Q1 revenue plunges 59% — May 12, 2026

Recent SRTS Insider Trades

Sachetta Eric bought 1.50K (~$5.00K) on May 12, 2026.
Sachetta Eric bought 2.00K (~$7.62K) on Feb 24, 2026.
Sachetta Eric bought 7.00K (~$27.51K) on Nov 21, 2025.

SRTS Analyst Consensus

3 analysts cover SRTS: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.67.

Common questions about SRTS

Who owns SRTS stock?: Hedge funds tracked by Rallies that own SRTS include Renaissance Technologies, Two Sigma, Citadel Advisors, and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sensus Healthcare, Inc.
Does Rallies show 13F holders for SRTS?: Yes. Rallies tracks hedge fund and 13F ownership data for SRTS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SRTS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SRTS. It does not provide personalized investment advice.